Grant Avenue Capital is a healthcare-focused private equity firm that partners with management teams to provide operational insight and flexible capital for growth. Specializing in control buyouts, corporate carve-outs, and special situations, the firm targets companies with $5-25 million EBITDA across services, devices, pharma, and HCIT sectors.
- Healthcare
- Home Health Care
- Hospice Care
- Consulting
- Life Sciences
- Technology Services
- Growth Management
- People Development
- Digital Transformation
- Cybersecurity
Leadership
| Name | Title | ||
|---|---|---|---|
| Buddy Gumina | Managing Partner |
in/buddy-gumina
|
|
| Partner |
|
|
|
| Principal |
|
|
|
| Principal |
|
|
|
| Managing Director |
|
|
Recent Transactions involving Grant Avenue Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Grant Avenue recapitalizes life sciences consultancy CREO |
CREO |
Grant Avenue Capital |
Healthcare and Life Sciences Consulting | |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →